Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 193

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting

Open access
Schmitt, Jochen, Spuls, Phyllis, Boers, Maarten, Thomas, Kim, Chalmers, Joanne, Roekevisch, Evelien, Schram, Mandy, Allsopp, Richard, Aoki, Valeria, Apfelbacher, Christian, Bruijnzeel‐Koomen, Carla, Bruin‐Weller, Marjolein, Charman, Carolyn, Cohen, Arnon, Dohil, Magdalene, Flohr, Carsten, Furue, Masutaka, Gieler, Uwe, Hooft, Lotty, Humphreys, Rosemary, Ishii, Henrique Akira, Katayama, Ichiro, Kouwenhoven, Willem, Langan, Sinéad, Lewis‐Jones, Sue, Merhand, Stephanie, Murota, Hiroyuki, Murrell, Dedee F., Nankervis, Helen, Ohya, Yukihiro, Oranje, Arnold, Otsuka, Hiromi, Paul, Carle, Rosenbluth, Yael, Saeki, Hidehisa, Schuttelaar, Marie‐Louise, Stalder, Jean‐Francois, Svensson, Åke, Takaoka, Roberto, Wahlgren, Carl‐Fredrik, Weidinger, Stephan, Wollenberg, Andreas, Williams, Hywel·2012·Allergy

Abstract

The use of nonstandardized and inadequately validated outcome measures in atopic eczema trials is a major obstacle to practising evidence‐based dermatology. The Harmonising Outcome Measures for Eczema (HOME) initiative is an international multiprofessional group dedicated to atopic eczema outcomes research. In June 2011, the HOME initiative conducted a consensus study involving 43 individuals from 10 countries, representing different stakeholders (patients, clinicians, methodologists, pharmaceutical industry) to determine core outcome domains for atopic eczema trials, to define quality criteria for atopic eczema outcome measures and to prioritize topics for atopic eczema outcomes research. Delegates were given evidence‐based information, followed by structured group discussion and anonymous consensus voting. Consensus was achieved to include clinical signs, symptoms, long‐term control of flares and quality of life into the core set of outcome domains for atopic eczema trials. The HOME initiative strongly recommends including and reporting these core outcome domains as primary or secondary endpoints in all future atopic eczema trials. Measures of these core outcome domains need to be valid, sensitive to change and feasible. Prioritized topics of the HOME initiative are the identification/development of the most appropriate instruments for the four core outcome domains. HOME is open to anyone with an interest in atopic eczema outcomes research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1398-9995.2012.02874.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 193

Metadata

Authors
Schmitt, J., Spuls, P., Boers, M., Thomas, K., Chalmers, J., Roekevisch, E., Schram, M., Allsopp, R., Aoki, V., Apfelbacher, C., Bruijnzeel‐Koomen, C., Bruin‐Weller, M., Charman, C., Cohen, A., Dohil, M., Flohr, C., Furue, M., Gieler, U., Hooft, L., Humphreys, R., Ishii, H. A., Katayama, I., Kouwenhoven, W., Langan, S., Lewis‐Jones, S., Merhand, S., Murota, H., Murrell, D. F., Nankervis, H., Ohya, Y., Oranje, A., Otsuka, H., Paul, C., Rosenbluth, Y., Saeki, H., Schuttelaar, M., Stalder, J., Svensson, Å., Takaoka, R., Wahlgren, C., Weidinger, S., Wollenberg, A., & Williams, H.
Venue
Allergy
Publisher
Wiley
Published
2012-07-30
Volume
67
Issue
9
Pages
1111-1117
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W2028924443
Cited by
193
References
4
FWCI
18.20
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. https://app.cochat.ai/papers/10.1111/j.1398-9995.2012.02874.x
The paper
Schmitt, J., Spuls, P., Boers, M., Thomas, K., Chalmers, J., Roekevisch, E., Schram, M., Allsopp, R., Aoki, V., Apfelbacher, C., Bruijnzeel‐Koomen, C., Bruin‐Weller, M., Charman, C., Cohen, A., Dohil, M., Flohr, C., Furue, M., Gieler, U., Hooft, L., . . . Williams, H. (2012). Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy. https://doi.org/10.1111/j.1398-9995.2012.02874.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.